Hindi Tamil Telugu
    More
    In the news
    Narendra Modi
    Amit Shah
    Box Office Collection
    Bharatiya Janata Party (BJP)
    OTT releases
    Hindi Tamil Telugu
    User Placeholder

    Hi,

    Logout

    India
    Business
    World
    Politics
    Sports
    Technology
    Entertainment
    Auto
    Lifestyle
    Inspirational
    Career
    Bengaluru
    Delhi
    Mumbai

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
    Home / News / India News / Are Indian vaccines effective against Omicron? Here's what manufacturers say
    Next Article
    Are Indian vaccines effective against Omicron? Here's what manufacturers say
    More data on the Omicron variant to ascertain COVID-19 vaccine efficacy will likely take “several weeks.”

    Are Indian vaccines effective against Omicron? Here's what manufacturers say

    By Pratyush Deep Kotoky
    Dec 01, 2021
    03:34 pm

    What's the story

    The COVID-19 vaccine manufacturers in India are reportedly waiting for "more data" on the new coronavirus variant, Omicron, to assess the efficacy of their vaccines.

    It is likely to take "several weeks" to ascertain whether vaccines are effective against Omicron, sources at the Serum Institute of India (SII), Bharat Biotech, and Zydus Cadila told CNN-News18.

    Context

    Why does it matter?

    It is feared that the Omicron variant may have the ability of immune escape, rendering vaccines ineffective.

    Omicron is said to be the most heavily mutated strain of the coronavirus SARS-CoV-2 detected so far.

    American vaccine-maker Moderna had said Tuesday that its COVID-19 vaccine is unlikely to be as effective against Omicron as the other variants.

    You're
    16%
    through

    COVAXIN

    'High chances' that COVAXIN remains effective

    There are "high chances" that COVAXIN may work against Omicron, a senior official at vaccine maker Bharat Biotech told CNN-News18.

    "COVAXIN was developed against the original Wuhan variant... it has shown that it can work against other variants, including Delta," the official said.

    New research over the new variant is also ongoing, the official added.

    You're
    33%
    through

    Covishield

    Need to wait and watch: SII official

    It is "too early" to ascertain whether Covishield (Oxford/AstraZeneca formulation) is effective against Omicron or requires tweaking, an SII official said.

    We need to wait and watch for several weeks, they said.

    Oxford Vaccine Group Director Andrew Pollard recently told BBC the existing vaccine should work against Omicron.

    It will take up to three weeks to see if Omicron evades current vaccinations, Pollard said.

    You're
    50%
    through

    ZyCoV-D

    Closely monitoring global data: Zydus Cadila

    Officials at vaccine manufacturer Zydus Cadila said they are "closely monitoring" the global data on Omicron.

    Its COVID-19 vaccine ZyCoV-D uses "plug and play technology," which allows the vaccine to be easily tweaked to provide protection against mutations, they said.

    "We need to do an easy tweaking if the situation demands it," they added.

    You're
    66%
    through

    Information

    Now, new vaccines could come up sooner

    Meanwhile, India's top officials said the platforms and processes of developing new vaccines or tweaking existing ones are "well-oiled." Hence, a new product could be launched quickly if the requirement arises, they said.

    You're
    83%
    through

    Global

    What do global manufacturers say?

    Moderna CEO Stéphane Bancel had recently said existing vaccines would be significantly less effective against Omicron.

    Pfizer is tailoring its mRNA vaccine to specifically target the new variant.

    Johnson & Johnson also said it is are "pursuing an Omicron-specific variant vaccine."

    Meanwhile, Sputnik-manufacturer, the Russian Direct Investment Fund (RDIF), said it is developing an adapted booster against Omicron.

    Done!
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Related News
    Latest
    Zydus Cadila
    Coronavirus
    Serum Institute of India
    Bharat Biotech

    Latest

    Heinrich Klaasen completes 300 sixes in T20s: Key stats Heinrich Klaasen
    Will MS Dhoni feature in IPL 2026? CSK captain clarifies Mahendra Singh Dhoni
    Travis Head completes 200 T20 sixes, 50 in IPL: Stats Sunrisers Hyderabad (SRH)
    IPL 2025, GT vs CSK: Our Player of the Day Chennai Super Kings (CSK)

    Zydus Cadila

    GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance India
    COVID KAVACH ELISA: First Indian antibody detection kit for coronavirus Harsh Vardhan
    India's second COVID-19 vaccine cleared for human trials: Details here Drugs Controller General of India
    COVID-19 vaccine: What are the latest updates? Oxford

    Coronavirus

    Government preparing to handle 4.5-5 lakh COVID-19 cases a day VK Paul
    Coronavirus: India reports 18K+ new cases, lowest in 7 months Union Health Ministry
    Coronavirus: India reports 18K+ new cases, lowest in 215 days Union Health Ministry
    Coronavirus: India reports 14K+ new cases, lowest in 224 days Union Health Ministry

    Serum Institute of India

    Maldives to become first foreign country to receive Covishield doses Maldives
    Pune: Fire breaks out at Serum Institute of India Pune
    Five killed in Serum Institute fire; Maharashtra government orders probe Pune
    Antonio Guterres saddened by life loss in Serum Institute fire Pune

    Bharat Biotech

    Meet India's frontline workers who received first COVID-19 vaccine shots Maharashtra
    Co-WIN app suffers glitches on 1st day of vaccination drive Madhya Pradesh
    Who shouldn't take COVAXIN? Maker Bharat Biotech issues fact-sheet Vaccine
    Centre issues a new Letter of Comfort to Bharat Biotech Coronavirus
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2025